ARTICLE | Clinical News
BioChaperone PDGF-BB: Phase III started
September 1, 2014 7:00 AM UTC
Adocia began a double-blind, placebo-controlled, Indian Phase III trial to evaluate BioChaperone PDGF-BB spray in 252 Type I and II diabetics with a chronic foot ulcer. In 4Q15, the company also plans...